| __timestamp | Madrigal Pharmaceuticals, Inc. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15746000 | 1860000 |
| Thursday, January 1, 2015 | 13392000 | 2963000 |
| Friday, January 1, 2016 | 9290000 | 6961000 |
| Sunday, January 1, 2017 | 7672000 | 11779000 |
| Monday, January 1, 2018 | 15293000 | 13697000 |
| Tuesday, January 1, 2019 | 22648000 | 15749000 |
| Wednesday, January 1, 2020 | 21864000 | 18638000 |
| Friday, January 1, 2021 | 37318000 | 27196000 |
| Saturday, January 1, 2022 | 48130000 | 31739000 |
| Sunday, January 1, 2023 | 108146000 | 33491000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing expenses is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Madrigal Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc. from 2014 to 2023. Over this period, Madrigal Pharmaceuticals saw a staggering increase in SG&A expenses, peaking at over 360% growth by 2023. In contrast, Protagonist Therapeutics experienced a more modest rise, with expenses growing by approximately 80% over the same period.
The data reveals a significant divergence in financial strategies. Madrigal's aggressive spending could indicate a focus on rapid expansion or intensive R&D efforts, while Protagonist's steadier approach might reflect a more conservative growth strategy. Understanding these trends provides valuable insights into each company's operational priorities and market positioning.
Who Optimizes SG&A Costs Better? GSK plc or Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing argenx SE and Protagonist Therapeutics, Inc.
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Madrigal Pharmaceuticals, Inc.
Bio-Techne Corporation or Madrigal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Who Optimizes SG&A Costs Better? Madrigal Pharmaceuticals, Inc. or CymaBay Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Madrigal Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Opthea Limited and Protagonist Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.